In Vivo CAR T-Cell Therapeutics With Umoja Biopharma's Dr. Andrew Scharenberg
Cell & Gene: The Podcast
The Importance of Building a Manufacturing Facility in the Cell and Gene Therapy Industry
This chapter highlights the decision to create their own manufacturing facility and the benefits it provides in terms of supply chain control and technological iteration. It also discusses the challenges and importance of industry experience in vector manufacturing for CAR T-cell therapeutics.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
